Page Comparison

Attendees:

JJ Harkema (Experian);

Scott Shorter (IAWG Vice-Chair); 

Matt King (SAFE-BioPharma);

David Simonetti (SAFE- BioPharma);

Richard Wilsher (Zygma);

Matt Williams (Exostar);

Colin Wallis ; Ruth Puenteand Ruth Puente (KI) 

Agenda: 

1. Welcome and Roll Call
2. Internet2 Update
3. Kantara Identity Assurance Working Group Update
4. SAFE-Biopharma Update
5. NIST and FICAM Updates
6. Open Mic

Incommon/Internet 2 Report

...

IAWG Report 

Update for IAWG.pdf

SAFE - Biopharma

...

Bio-Pharma Update 

• No further news from NIST.
• They also noted that the "authoritative sources" requirement is a challenge. 
• They have seen interest from companies to be certified against 800-63-3. There seem to be a requirement from the Insurance, Banking and Healthcare industries on 63-3 compliance. 
• Regarding AL2 minus, there have seen interest on something in between AL1 and AL2. 

NIST SP 800-63-3 

• Scott Shorter provided the link to NIST FAQ: https://pages.nist.gov/800-63-FAQ/
  
• Exostar commented that as they do not have a regulatory requirement or use case .  they still do not have a specific strategy towards 63-3.